Your browser doesn't support javascript.
loading
Construction and Characterization of the Mycobacterium tuberculosis sigE fadD26 Unmarked Double Mutant as a Vaccine Candidate.
Hernandez-Pando, Rogelio; Shin, Sung Jae; Clark, Simon; Casonato, Stefano; Becerril-Zambrano, Martin; Kim, Hongmin; Boldrin, Francesca; Mata-Espinoza, Dulce; Provvedi, Roberta; Arbues, Ainhoa; Marquina-Castillo, Brenda; Cioetto Mazzabò, Laura; Barrios-Payan, Jorge; Martin, Carlos; Cho, Sang-Nae; Williams, Ann; Manganelli, Riccardo.
Afiliação
  • Hernandez-Pando R; Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiràn, Mexico City, Mexico.
  • Shin SJ; Department of Microbiology, Institute for Immunology and Immunological Disease, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.
  • Clark S; Public Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
  • Casonato S; Department of Molecular Medicine, University of Padova, Padua, Italy.
  • Becerril-Zambrano M; Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiràn, Mexico City, Mexico.
  • Kim H; Department of Microbiology, Institute for Immunology and Immunological Disease, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.
  • Boldrin F; Department of Molecular Medicine, University of Padova, Padua, Italy.
  • Mata-Espinoza D; Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiràn, Mexico City, Mexico.
  • Provvedi R; Department of Biology, University of Padova, Padua, Italy.
  • Arbues A; Departamento de Microbiología, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain.
  • Marquina-Castillo B; Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiràn, Mexico City, Mexico.
  • Cioetto Mazzabò L; Department of Molecular Medicine, University of Padova, Padua, Italy.
  • Barrios-Payan J; Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiràn, Mexico City, Mexico.
  • Martin C; Departamento de Microbiología, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain.
  • Cho SN; Department of Microbiology, Institute for Immunology and Immunological Disease, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.
  • Williams A; Public Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom.
  • Manganelli R; Department of Molecular Medicine, University of Padova, Padua, Italy riccardo.manganelli@unipd.it.
Infect Immun ; 88(1)2019 12 17.
Article em En | MEDLINE | ID: mdl-31591165
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator sigma / Tuberculose Pulmonar / Vacinas contra a Tuberculose / Ligases / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator sigma / Tuberculose Pulmonar / Vacinas contra a Tuberculose / Ligases / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article